CHRS – coherus biosciences, inc. (US:NASDAQ)

News

Coherus Oncology (NASDAQ:CHRS) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer [Yahoo! Finance]
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com